Letters Community acquired pneumonia

Antibiotic coverage is atypical: evidence from randomised trials

BMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39409.402894.BE (Published 29 November 2007) Cite this as: BMJ 2007;335:1109
  1. Leonard Leibovici, head, Department of Medicine E,
  2. Eyal Robenshtock, senior physician, Department of Medicine E,
  3. Mical Paul, consultant, Infectious Diseases Unit
  1. Beilinson Campus, Rabin Medical Centre, Petah-Tiqva, Israel
  1. leibovic{at}post.tau.ac.il

    Bjerre quotes an observational study to support the addition of antibiotics that cover atypical pathogens to the treatment of patients with community acquired pneumonia.1 The results of randomised controlled trials dealing with this question were amassed in two recent systematic reviews and meta-analyses (one published in the BMJ …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe